Sunshine Act Meetings, 29520 [E9-14649]

Download as PDF 29520 Federal Register / Vol. 74, No. 118 / Monday, June 22, 2009 / Notices NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (09–055)] NASA Advisory Council; Meeting AGENCY: National Aeronautics and Space Administration. ACTION: Notice of meeting. SUMMARY: In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, the National Aeronautics and Space Administration announces a meeting of the NASA Advisory Council. The agenda for the meeting includes updates from each of the Council committees, including discussion and deliberation of potential recommendations. The Council Committees address NASA’s work in the following areas: Aeronautics, Audit and Finance, Space Exploration, Human Capital, Science, and Space Operations. DATES: Thursday, July 16, 2009, 8 a.m.– 4:30 p.m. ADDRESSES: Columbia Ballroom, The Holiday Inn Capitol, 550 C Street, SW., Washington, DC 20024. FOR FURTHER INFORMATION CONTACT: Ms. Marguerite Broadwell, Designated Federal Official, National Aeronautics and Space Administration, Washington, DC, 20546, 202/358–1894. SUPPLEMENTARY INFORMATION: The meeting will be open to the public up to the seating capacity of the room. It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. Dated: June 16, 2009. P. Diane Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. E9–14605 Filed 6–19–09; 8:45 am] BILLING CODE 7510–13–P July 22, 2009, 8:30 a.m.–11 a.m.—Open. AGENDA: Public Comment Sessions; Emergency Preparedness; Housing; Developmental Disabilities and Bill of Rights Act, Workforce Infrastructure, International Development, 2010 National Summit on Disability Policy, United States Marine Corps Research Project, 2011 Strategic Planning, Reports from the Chairperson, Council Members, and the Executive Director; Unfinished Business; New Business; Announcements; Adjournment. SUNSHINE ACT MEETING CONTACT: Mark S. Quigley, Director of External Affairs, NCD, 1331 F Street, NW., Suite 850, Washington, DC 20004; 202–272–2004 (voice), 202–272–2074 (TTY), 202–272– 2022 (fax). AGENCY MISSION: NCD is an independent federal agency, composed of 15 members appointed by the President, by and with the consent of the U.S. Senate. The purpose of the NCD is to promote policies, programs, practices, and procedures that guarantee equal opportunity for all individuals with disabilities, and that empower individuals with disabilities to achieve economic self-sufficiency, independent living, and inclusion and integration into all aspects of society. To carry out this mandate we gather public and stakeholder input, including that received at our public meetings held around the country; review and evaluate Federal programs and legislation; and provide the President, Congress and federal agencies with advice and recommendations. ACCOMMODATIONS: Those needing reasonable accommodations should notify NCD immediately. Dated: June 9, 2009. Michael C. Collins, Executive Director. [FR Doc. E9–14649 Filed 6–18–09; 11:15 am] BILLING CODE 6820–MA–P NATIONAL COUNCIL ON DISABILITY NUCLEAR REGULATORY COMMISSION Sunshine Act Meetings TYPE: Quarterly Meeting. [Docket No. 030–36482; NRC–2009–0253] pwalker on PROD1PC71 with NOTICES DATES AND TIMES: July 20, 2009, 8:30 a.m.–4:30 p.m. July 21, 2009, 9 a.m.–5 p.m. July 22, 2009, 8:30 a.m.–11 a.m. LOCATION: Minneapolis Marriott City Center, 30 South 7th Street, Minneapolis, MN 55402. STATUS: July 20, 2009, 8:30 a.m.–4:30 p.m.— Open. July 21, 2009, 9 a.m.–5 p.m.—Open. July 22, 2009, 8 a.m.–8:30 a.m.—Closed Executive Session. VerDate Nov<24>2008 16:55 Jun 19, 2009 Jkt 217001 Notice of Environmental Assessment Related to the Issuance of a License Amendment to Byproduct Material License No. 24–32439–01, for the Unrestricted Release of a Pharmacia Corporation Building in St. Louis, MO AGENCY: Nuclear Regulatory Commission. ACTION: Issuance of environmental assessment and finding of no significant impact for license amendment. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 FOR FURTHER INFORMATION CONTACT: Katie Streit, Health Physicist, Materials Control, ISFSI, and Decommissioning Branch, Division of Nuclear Materials and Safety, Region III, U.S. Nuclear Regulatory Commission, 2443 Warrenville Road, Lisle, Illinois 60532; telephone: (630) 829–9621; fax number: (630) 515–1259; or by email at Katherine.Streit@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The U.S. Nuclear Regulatory Commission (NRC) is considering the issuance of an amendment to NRC Byproduct Materials License No. 24– 32439–01, which is held by The Pharmacia Corporation (the licensee), a wholly owned subsidiary of Pfizer, Inc. The issuance of the amendment would approve the licensee’s April 1, 2009, request (ML090920862) to release for unrestricted use its building located at 645 South Newstead Avenue, St. Louis, Missouri (the Facility). The NRC has prepared an Environmental Assessment (EA) in support of this proposed action in accordance with the requirements of Title 10, Code of Federal Regulations (CFR), Part 51 (10 CFR part 51). Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate with respect to the proposed action. The amendment will be issued to the licensee following the publication of this FONSI and EA in the Federal Register. II. Environmental Assessment Identification of Proposed Action The proposed action would approve the licensee’s April 1, 2009, license amendment request, resulting in the release of the Facility for unrestricted use consistent with the provisions of 10 CFR Part 20, Subpart E. The licensee was issued License No. 24–32439–01 on April 08, 2004, pursuant to 10 CFR Part 30, and the license has been amended periodically since that time. The license authorized the use of unsealed and sealed byproduct materials for conducting research and development activities, which included animal studies, gas chromatographs, and an irradiator. The Facility is a two storybuilding with an annex that contained research laboratories, offices, vivarium space, and other mechanical support areas. The licensee ceased licensed activities at the Facility during March 2009 and initiated a survey and decontamination activities there. Based on the licensee’s historical knowledge of the site and the Facility, the licensee determined that E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 74, Number 118 (Monday, June 22, 2009)]
[Notices]
[Page 29520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-14649]


-----------------------------------------------------------------------

NATIONAL COUNCIL ON DISABILITY


Sunshine Act Meetings

Type: Quarterly Meeting.

Dates and Times: 
July 20, 2009, 8:30 a.m.-4:30 p.m.
July 21, 2009, 9 a.m.-5 p.m.
July 22, 2009, 8:30 a.m.-11 a.m.

Location: Minneapolis Marriott City Center, 30 South 7th Street, 
Minneapolis, MN 55402.

Status: 
July 20, 2009, 8:30 a.m.-4:30 p.m.--Open.
July 21, 2009, 9 a.m.-5 p.m.--Open.
July 22, 2009, 8 a.m.-8:30 a.m.--Closed Executive Session.
July 22, 2009, 8:30 a.m.-11 a.m.--Open.

Agenda: Public Comment Sessions; Emergency Preparedness; Housing; 
Developmental Disabilities and Bill of Rights Act, Workforce 
Infrastructure, International Development, 2010 National Summit on 
Disability Policy, United States Marine Corps Research Project, 2011 
Strategic Planning, Reports from the Chairperson, Council Members, and 
the Executive Director; Unfinished Business; New Business; 
Announcements; Adjournment.

Sunshine Act Meeting Contact: Mark S. Quigley, Director of External 
Affairs, NCD, 1331 F Street, NW., Suite 850, Washington, DC 20004; 202-
272-2004 (voice), 202-272-2074 (TTY), 202-272-2022 (fax).

Agency Mission: NCD is an independent federal agency, composed of 15 
members appointed by the President, by and with the consent of the U.S. 
Senate. The purpose of the NCD is to promote policies, programs, 
practices, and procedures that guarantee equal opportunity for all 
individuals with disabilities, and that empower individuals with 
disabilities to achieve economic self-sufficiency, independent living, 
and inclusion and integration into all aspects of society. To carry out 
this mandate we gather public and stakeholder input, including that 
received at our public meetings held around the country; review and 
evaluate Federal programs and legislation; and provide the President, 
Congress and federal agencies with advice and recommendations.

Accommodations: Those needing reasonable accommodations should notify 
NCD immediately.

    Dated: June 9, 2009.
Michael C. Collins,
Executive Director.
[FR Doc. E9-14649 Filed 6-18-09; 11:15 am]
BILLING CODE 6820-MA-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.